The first inkling that drummer Zak Starkey had that something might be amiss, was a feeling of 'muscle tightness' in his ...

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) has issued a complete response letter ...

UNC Charlotte students gathered this weekend for the annual Ninerthon 2025, a dance marathon that raised funds for Levine ...

The protocols offer a more accurate way to detect atherosclerosis and assess cardiovascular risk before symptoms appear, ...

In this expert perspective, Manjot K. Gill, MD, discusses faricimab for the management of retinal vein occlusion.

| Mass General's Dr. Matthew Eagleton highlights advances in minimally invasive techniques, the need for greater public awareness and the role AI could play in personalized vascular care.

In this expert perspective, Manjot K. Gill, MD, discusses the potential FDA approval in 2025 of aflibercept 8 mg for the treatment of retinal vein occlusion.